JP2010517991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010517991A5 JP2010517991A5 JP2009547779A JP2009547779A JP2010517991A5 JP 2010517991 A5 JP2010517991 A5 JP 2010517991A5 JP 2009547779 A JP2009547779 A JP 2009547779A JP 2009547779 A JP2009547779 A JP 2009547779A JP 2010517991 A5 JP2010517991 A5 JP 2010517991A5
- Authority
- JP
- Japan
- Prior art keywords
- condition
- composition
- compound
- composition according
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 claims 2
- 108090000079 Glucocorticoid Receptors Proteins 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- -1 2-methylpyridin-3-yl Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88798107P | 2007-02-02 | 2007-02-02 | |
| PCT/IB2008/000249 WO2008093236A1 (en) | 2007-02-02 | 2008-01-28 | Tricyclic compounds and their use as glucocorticoid receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010517991A JP2010517991A (ja) | 2010-05-27 |
| JP2010517991A5 true JP2010517991A5 (enExample) | 2010-09-24 |
| JP4579333B2 JP4579333B2 (ja) | 2010-11-10 |
Family
ID=39887754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547779A Expired - Fee Related JP4579333B2 (ja) | 2007-02-02 | 2008-01-28 | 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2114888B1 (enExample) |
| JP (1) | JP4579333B2 (enExample) |
| AP (1) | AP2411A (enExample) |
| AT (1) | ATE487700T1 (enExample) |
| AU (1) | AU2008211622B2 (enExample) |
| BR (1) | BRPI0807121A2 (enExample) |
| CA (1) | CA2676907C (enExample) |
| DE (1) | DE602008003405D1 (enExample) |
| DK (1) | DK2114888T3 (enExample) |
| EA (1) | EA016001B1 (enExample) |
| HR (1) | HRP20100726T1 (enExample) |
| IL (1) | IL200044A (enExample) |
| MX (1) | MX2009008286A (enExample) |
| NZ (1) | NZ578661A (enExample) |
| PL (1) | PL2114888T3 (enExample) |
| SI (1) | SI2114888T1 (enExample) |
| UZ (1) | UZ4378C (enExample) |
| WO (1) | WO2008093236A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20110702T1 (hr) * | 2007-02-02 | 2011-10-31 | Pfizer Products Inc. | Triciklički spojevi i njihova uporaba kao modulatora glukokortikoidnih receptora |
| ES2527137T3 (es) * | 2008-07-28 | 2015-01-21 | Pfizer Inc. | Compuestos de fenantrenona, composiciones y procedimientos |
| WO2012125797A1 (en) * | 2011-03-15 | 2012-09-20 | Abbott Laboratories | Nuclear hormone receptor modulators |
| US20140350078A1 (en) * | 2011-09-13 | 2014-11-27 | New York University | Controlling regulatory t cell function |
| TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
| WO2014094357A1 (en) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Heterocyclic nuclear hormone receptor modulators |
| SI3350175T1 (sl) * | 2015-09-15 | 2020-04-30 | Leo Pharma A/S | Nesteroidni modulatorji glukokortikoidnega receptorja za lokalno dostavo zdravila |
| SG11202106444WA (en) | 2018-12-19 | 2021-07-29 | Leo Pharma As | Amino-acid anilides as small molecule modulators of il-17 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01011018A (es) * | 1999-04-30 | 2002-05-06 | Pfizer Prod Inc | Moduladores del receptor glucocorticoide. |
| JP4738603B2 (ja) * | 2000-11-06 | 2011-08-03 | ライオン株式会社 | 歯ブラシ |
| IL146057A (en) * | 2000-10-27 | 2007-09-20 | Pfizer Prod Inc | A process for the preparation of modulators of a non-steroidal glucocorticoid receptor |
| ES2262612T3 (es) * | 2000-10-28 | 2006-12-01 | Pfizer Products Inc. | Moduladpres del receptor de glucocorticoides. |
| CA2545020A1 (en) * | 2003-11-13 | 2005-05-26 | Pfizer Products Inc. | Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| JP2009535430A (ja) * | 2006-05-02 | 2009-10-01 | コーセプト セラピューティクス， インコーポレイテッド | Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用 |
-
2008
- 2008-01-28 EP EP08702358A patent/EP2114888B1/en active Active
- 2008-01-28 AP AP2009004941A patent/AP2411A/xx active
- 2008-01-28 MX MX2009008286A patent/MX2009008286A/es active IP Right Grant
- 2008-01-28 JP JP2009547779A patent/JP4579333B2/ja not_active Expired - Fee Related
- 2008-01-28 AU AU2008211622A patent/AU2008211622B2/en not_active Ceased
- 2008-01-28 SI SI200830124T patent/SI2114888T1/sl unknown
- 2008-01-28 DE DE602008003405T patent/DE602008003405D1/de active Active
- 2008-01-28 CA CA2676907A patent/CA2676907C/en not_active Expired - Fee Related
- 2008-01-28 AT AT08702358T patent/ATE487700T1/de active
- 2008-01-28 BR BRPI0807121-7A2A patent/BRPI0807121A2/pt not_active Application Discontinuation
- 2008-01-28 PL PL08702358T patent/PL2114888T3/pl unknown
- 2008-01-28 EA EA200970662A patent/EA016001B1/ru not_active IP Right Cessation
- 2008-01-28 UZ UZ0900241A patent/UZ4378C/xx unknown
- 2008-01-28 HR HR20100726T patent/HRP20100726T1/hr unknown
- 2008-01-28 NZ NZ578661A patent/NZ578661A/en not_active IP Right Cessation
- 2008-01-28 WO PCT/IB2008/000249 patent/WO2008093236A1/en not_active Ceased
- 2008-01-28 DK DK08702358.6T patent/DK2114888T3/da active
-
2009
- 2009-07-23 IL IL200044A patent/IL200044A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010517990A5 (enExample) | ||
| JP2010517991A5 (enExample) | ||
| JP2010533203A5 (enExample) | ||
| JP2011037901A5 (enExample) | ||
| JP2009530283A5 (enExample) | ||
| ATE531711T1 (de) | Für die behandlung von autoimmunerkrankungen und entzündlichen erkrankungen geeignete tetrahydrocyclopentaäbüindol-3- ylcarbonsäurederivate | |
| JP2010536766A5 (enExample) | ||
| JP2009535462A5 (enExample) | ||
| JP2010504286A5 (enExample) | ||
| JP2007537295A5 (enExample) | ||
| JP2012523440A5 (enExample) | ||
| JP2009161554A5 (enExample) | ||
| JP2012502111A5 (enExample) | ||
| JP2010530897A5 (enExample) | ||
| JP2010535870A5 (enExample) | ||
| JP2009543861A5 (enExample) | ||
| JP2010523692A5 (enExample) | ||
| JP2019501927A5 (enExample) | ||
| JP2016540749A5 (enExample) | ||
| JP2016507581A5 (enExample) | ||
| JP2010536889A5 (enExample) | ||
| JP2010508335A5 (enExample) | ||
| JP2009539848A5 (enExample) | ||
| CA2676907A1 (en) | Tricyclic compounds and their use as glucocorticoid receptor modulators | |
| JP2012509265A5 (enExample) |